SCHEMBL6589695

SCHEMBL6589695

Cc1ccc([N+](=O)[O-])c(N/C(=C\C(=O)O)C(=O)O)c1

nearest known ligand 0.52

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.52
MAPT P10636 2/20 0.48
NPSR1 Q6W5P4 1/20 0.47
RXFP1 Q9HBX9 1/20 0.47
CYP3A4 P08684 1/20 0.45
TSHR P16473 1/20 0.45
KAT2B Q92831 1/20 0.44
KCNMA1 Q12791 1/20 0.41
KDM4E B2RXH2 1/20 0.41
KMT2A Q03164 1/20 0.41
GRK6 P43250 1/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6589698 1.00 ALDH1A1 (0.52) ALDH1A1MAPTNPSR1RXFP1CYP3A4
SCHEMBL6589705 1.00 ALDH1A1 (0.52) ALDH1A1MAPTNPSR1RXFP1CYP3A4
SCHEMBL6587315 0.89 ALDH1A1 (0.66) ALDH1A1MAPTKCNMA1KDM4EKMT2A
SCHEMBL6587311 0.89 ALDH1A1 (0.66) ALDH1A1MAPTKCNMA1KDM4EKMT2A
SCHEMBL6587318 0.89 ALDH1A1 (0.66) ALDH1A1MAPTKCNMA1KDM4EKMT2A
SCHEMBL6080536 0.88 MAPT (0.51) ALDH1A1MAPTNPSR1RXFP1CYP3A4
SCHEMBL6583771 0.80 MEN1 (0.62) ALDH1A1MAPTNPSR1CYP3A4KCNMA1
SCHEMBL6583773 0.80 MEN1 (0.62) ALDH1A1MAPTNPSR1CYP3A4KCNMA1
SCHEMBL6583777 0.80 MEN1 (0.62) ALDH1A1MAPTNPSR1CYP3A4KCNMA1
SCHEMBL10874791 0.78 ALDH1A1 (0.66) ALDH1A1MAPTNPSR1CYP3A4TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1451159-A1 COMPOSITIONS DERIVED FROM QUINOLINE AND QUINOXALINE, PREPARATION AND USE THEREOF NEURO3D (FR) 2004-09-01 EP disclosed
WO-2003010146-A1 COMPOSITIONS DERIVED FROM QUINOLINE AND QUINOXALINE, PREPARATION AND USE THEREOF NEURO3D (FR) 2003-02-06 WO disclosed